Patient-Related Barriers (SESSION)
On-Demand Video
This presentation was a part of the SOCS Meeting The Challenge Summit: Diversity in Dermatology Clinical Trials held on June 10-11, 2022 in Washington, DC. The length of the course is 60 minutes.
WHY DON’T YOU SEE ME? INSIGHTS FROM POTENTIAL CLINICAL TRIAL PARTICIPANTS
Jocelyn M. Ashford is the Head of Cardiorenal Global Patient Advocacy at BridgeBio, a clinical-stage biopharmaceutical company focused on genetic diseases and cancers with clear genetic drivers. She is dedicated to strengthening relationships with patient advocacy organizations and the broader community. Before joining the BridgeBio family, Jocelyn was at Genentech where she led advocacy relations efforts to address the unmet needs in various rare and not-so-rare Respiratory and Immunology communities. Jocelyn holds a Bachelor’s in Industrial Engineering & Economics. She completed her Master’s work in Engineering Management and Social & Organizational Change at Northwestern University in Evanston, IL.
PRACTICE VS GESTURE: ELIMINATING PATIENT BARRIERS TO EMPOWERED INCLUSION IN CLINICAL RESEARCH
Gretchen C. Wartman is Vice President for Policy and Program of the National Minority Quality Forum (NMQF), and Director of the NMQF Institute for Equity in Health Policy and Practice. Ms. Wartman also directs the NMQF National Alliance for Brain Health and Awareness. Ms. Wartman has more than 40 years of experience in the public and private sectors in health policy strategy and analysis, issue advocacy, and program administration. Prior to her tenure with NMQF, Ms. Wartman held positions with the Missouri Department of Health and Senior Services, including serving as the Title V/Maternal and Child Health Director, and Director of the Division of Nutritional Health and Services. Ms. Wartman is a Peer Reviewer for the Journal of Healthcare, Science and The Humanities.